Freenome (FRNM US): Synthetic Expert Call Transcript (21 Aug 2026)
Primary Care Physicians (PCPs) will not adopt blood-based colorectal cancer (CRC) screening as a first-line option due to its poor advanced...
105 Views
IPO Databook: Freenome (FRNM US) - Aug 2026
Freenome, Inc. is an early cancer detection company developing blood-based tests leveraging AI/ML to transform multi-cancer and multi-disease...
106 Views
No more insights